下一个

自动播放

PM1183 plus doxorubicin shows interesting activity in small cell lung cancer

2 意见 • 07/14/23
分享
嵌入
administrator
administrator
订户
0

Visit http://www.ecancer.org for more

Dr Calvo (START Madrid, Madrid, Spain) talks to ecancertv at ASCO 2015 about data from a Phase 1b study of the transcriptional inhibitor PM1183 in combination with doxorubicin in second line therapy in patients with small cell lung cancer (SCLC)

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放